NASDAQ:JAGX

Jaguar Health Stock Forecast, Price & News

$1.30
-0.11 (-7.80 %)
(As of 04/16/2021 04:00 PM ET)
Add
Compare
Today's Range
$1.20
Now: $1.30
$1.34
50-Day Range
$1.41
MA: $1.95
$2.25
52-Week Range
$0.19
Now: $1.30
$4.47
Volume15.50 million shs
Average Volume32.86 million shs
Market Capitalization$169.04 million
P/E RatioN/A
Dividend YieldN/A
Beta1.83
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
Jaguar Health logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:JAGX
CUSIPN/A
Phone(415) 371-8300
Employees29
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.78 million
Book Value$0.16 per share

Profitability

Net Income$-38,540,000.00
Net Margins-372.81%

Miscellaneous

Market Cap$169.04 million
Next Earnings Date5/21/2021 (Estimated)
OptionableNot Optionable

Headlines

Jaguar Health, Inc.: Jaguar Health Launches Website for Napo EU
February 23, 2021 |  finanznachrichten.de
Jaguar Health Launches Website for Napo EU
February 23, 2021 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.88 out of 5 stars

Medical Sector

1141st out of 2,025 stocks

Pharmaceutical Preparations Industry

509th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$1.30
-0.11 (-7.80 %)
(As of 04/16/2021 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive JAGX News and Ratings via Email

Sign-up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Jaguar Health (NASDAQ:JAGX) Frequently Asked Questions

What stocks does MarketBeat like better than Jaguar Health?

Wall Street analysts have given Jaguar Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Jaguar Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Jaguar Health?

Jaguar Health saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 4,970,000 shares, an increase of 26.1% from the March 15th total of 3,940,000 shares. Based on an average trading volume of 23,960,000 shares, the days-to-cover ratio is currently 0.2 days.
View Jaguar Health's Short Interest
.

When is Jaguar Health's next earnings date?

Jaguar Health is scheduled to release its next quarterly earnings announcement on Friday, May 21st 2021.
View our earnings forecast for Jaguar Health
.

How were Jaguar Health's earnings last quarter?

Jaguar Health, Inc. (NASDAQ:JAGX) released its quarterly earnings results on Sunday, November, 15th. The biotechnology company reported ($0.21) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.11) by $0.10. The biotechnology company earned $2.77 million during the quarter. Jaguar Health had a negative net margin of 372.81% and a negative trailing twelve-month return on equity of 659.73%.
View Jaguar Health's earnings history
.

How has Jaguar Health's stock been impacted by COVID-19?

Jaguar Health's stock was trading at $0.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, JAGX stock has increased by 188.9% and is now trading at $1.30.
View which stocks have been most impacted by COVID-19
.

Who are Jaguar Health's key executives?

Jaguar Health's management team includes the following people:
  • Lisa A. Conte, President, Chief Executive Officer & Director
  • Carol R. Lizak, Chief Financial & Accounting Officer, SVP-Finance
  • Pravin R. Chaturvedi, Chief Scientific Officer
  • Jonathan S. Wolin, Chief of Staff & Chief Compliance Officer
  • Ian H. Wendt, Chief Commercial Officer

Who are some of Jaguar Health's key competitors?

What other stocks do shareholders of Jaguar Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT).

When did Jaguar Health IPO?

(JAGX) raised $22 million in an initial public offering on Wednesday, May 13th 2015. The company issued 3,200,000 shares at a price of $7.00 per share. Aegis Capital Corp acted as the underwriter for the IPO and CRT Capital and Feltl and Company were co-managers.

What is Jaguar Health's stock symbol?

Jaguar Health trades on the NASDAQ under the ticker symbol "JAGX."

How do I buy shares of Jaguar Health?

Shares of JAGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Jaguar Health's stock price today?

One share of JAGX stock can currently be purchased for approximately $1.30.

How much money does Jaguar Health make?

Jaguar Health has a market capitalization of $169.04 million and generates $5.78 million in revenue each year. The biotechnology company earns $-38,540,000.00 in net income (profit) each year or ($6.89) on an earnings per share basis.

How many employees does Jaguar Health have?

Jaguar Health employs 29 workers across the globe.

What is Jaguar Health's official website?

The official website for Jaguar Health is www.jaguaranimalhealth.com.

Where are Jaguar Health's headquarters?

Jaguar Health is headquartered at 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105.

How can I contact Jaguar Health?

Jaguar Health's mailing address is 201 MISSION STREET SUITE 2375, SAN FRANCISCO CA, 94105. The biotechnology company can be reached via phone at (415) 371-8300.


This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.